Regarding yesterday’s article in the Wall Street Journal entitled "Doctor's Paid to Prescribe Generic Pills" by Vanessa Fuhrman:
We have a very real crisis in America and it is our healthcare system. It is downright scary the direction it is headed. And no one has more experience with the broken system than patients with serious illnesses and their caregivers.
The journal article is about health insurance companies paying doctors financial incentives to move their patients over to generic drugs. Many of us caregivers deal with managing multiple medications. It doesn’t matter if a prescription is directly aimed at an area of illness or it is to manage some of the symptoms that present themselves – they are an important part of life in this world.
My daughter Meg has a number of prescriptions she requires on a regular basis – CoQ10, Synthroid, Carnetene, Neocate Junior, Bactrim, and Zyrtec. At least one of these has a generic version coming available at the end of this month. For us, the decision to move to a generic version of one of Meg’s meds will be front and center in early February. My wife Kim and I will look at moving to generics because they will most likely incur a lower insurance co-payment.
Insurance companies push people over to the generic version of a drug by significantly increasing your co-pay on the non-generic version.This is usually how people find out - their co-payment goes up on the generic and they ask the pharmacist why. Do not depend on your doctor to tell you that a generic version of a drug is available – our own did not tell us.
So we’ll talk to our doctor and our pharmacist, do a little research on the web about the new generic, and then collectively make a decision if we should move Meg over to it. Kim and I make sure we are part of all the decisions related to Meghan's care and work with all the professionals involved in her care.
But what upsets me about the Wall Street Journal article is that, more and more, insurance companies are attempting to get doctors to move to generics through financial incentives. We know Meg’s doctors fairly well and we're quite sure that none of them would change our daughter's meds based solely on a financial incentive from an insurance company. A doctor’s responsibility is to provide the best care available to their patients, not to help insurance companies and the generic pharmaceutical industry make profits. And our experience with doctors bears that out.
So how do we know when we’re being steered to a generic drug because of a kickback? How do we get the assistance we need throughout the decision-making process of moving to generics?
I would love to hear people’s thoughts on this one as it hits very close to home for all caregivers and their loved ones.
Brian Costello
carespace.com
More to read:
http://epablog.wordpress.com/2007/11/26/kickbacks-doctors-pharma-insurance-and-surprise-patients-caught-in-the-middle/
http://www.thebostonchannel.com/news/13800173/detail.html